Related Experiment Videos
Microalbuminuria and progressive renal disease
1Department of Medicine, Cook County Hospital, Chicago, IL.
Journal of Human Hypertension
|November 1, 1994
Summary
Microalbuminuria, a marker of kidney disease in diabetes and hypertension, predicts cardiovascular risk. While its reduction shows potential for renal survival, direct functional benefits in humans remain unproven.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Microalbuminuria indicates increased cardiovascular risk in hypertensive and diabetic patients.
- It's linked to metabolic and hemodynamic issues, correlating with glycosylated hemoglobin in diabetics.
- Pathogenesis involves glomerular changes, increased pressure, and altered cell permeability.
Purpose of the Study:
- To review the significance of microalbuminuria as a cardiovascular and renal risk marker.
- To discuss the multifactorial pathogenesis and screening methods.
- To evaluate the impact of interventions on microalbuminuria and renal outcomes.
Main Methods:
- Review of existing literature on microalbuminuria, hypertension, and diabetes.
- Discussion of diagnostic tools like the urine Micral test and radioimmunoassay.
- Analysis of therapeutic strategies including blood pressure control and lifestyle modifications.
Main Results:
- Microalbuminuria is a strong predictor of cardiovascular morbidity and mortality.
- Aggressive blood pressure control with specific antihypertensive agents is crucial for renal preservation.
- Reduced protein intake and glucose control may lower microalbuminuria, but direct human studies on functional renal benefit are lacking.
Conclusions:
- Microalbuminuria is a key risk factor for diabetic nephropathy and hypertensive renal disease.
- While reduction strategies exist, definitive proof of functional or structural renal benefit in humans is pending.
- Albuminuria reduction may offer renal survival benefits independent of blood pressure changes.